Journal of Clinical Virology
Volume 35, Issue 2 , Pages 121-129 , February 2006

Increasing incidence of mumps in Scotland: Options for reducing transmission

  • Martin Donaghy

      Affiliations

    • Health Protection Scotland, Clifton House, Clifton Place, Glasgow, Scotland G3 7LN, UK
    • ,
  • J. Claire Cameron

      Affiliations

    • Health Protection Scotland, Clifton House, Clifton Place, Glasgow, Scotland G3 7LN, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 141 300 1191; fax: +44 141 300 1170.
    • ,
  • Vera Friederichs

      Affiliations

    • Health Protection Scotland, Clifton House, Clifton Place, Glasgow, Scotland G3 7LN, UK
    • Department of Statistics and Modelling Science, University of Strathclyde, Livingstone Tower, Richmond Street, Glasgow, Scotland G1 1XT, UK

,Accepted 23 September 2005.

References 

  1. Arday DR, Kanjarpane DD, Kelley PW. Mumps in the US Army 1980–1986: should recruits be immunized?. Am J Public Health. 1989;79:471–474
  2. Bramley JC, Wallace LA, Ahmed S, Duff R, Carman WF, Cameron SO, et al. Universal hepatitis B vaccination of UK adolescents: a feasibility and acceptability study. Commun Dis Public Health. 2002;5:318–320
  3. Broliden K, Abreu ER, Arneborn M, Bottiger M. Immunity to mumps before and after MMR vaccination at 12 years of age in the first generation offered the two-dose immunization programme. Vaccine. 1998;16:323–327
  4. Chief Medical Officer. Mumps outbreaks in Scotland: offer of MMR to high-risk individuals in high risk settings. Scottish Executive, Edinburgh 2004.
  5. In:  Chin J editors. Control of Communicable Diseases Manual. Washington: American Public Health Association; 2000;
  6. Davidkin I, Valle M, Julkunen I. Persistence of anti-mumps virus antibodies after a two-dose MMR vaccination: a 9-year follow-up. Vaccine. 1995;13:1617–1622
  7. Department of Health, Welsh Office, Scottish Office Department of Health, DHSS (Northern Ireland). Immunisation against Infectious Disease, HMSO, London. 1996.
  8. Farrington CP, Kanaan MN. Estimation of the basic reproduction number for infectious diseases from age-stratified serological survey data. Appl Stat. 2001;50:251–292
  9. Fine PEM. Community Immunity. In:  Plotkin SA,  Orenstein WA editor. Vaccines. Philadelphia: Saunders; 2004;
  10. Galbraith NS, Young SEJ, Pusey JJ, Crombie DL, Sparks JP. Mumps surveillance in England and Wales 1962–1981. Lancet. 1984;1:91–94
  11. Germann D, Matter L. Raising the immunization rate in medical students against measles, mumps and rubella at the University of Berne. NHS Centre for Reviews and Dissemination. 1999;http://nhscrd.york.ac.uk/online/nhseed/19990822.htm
  12. Hall R, Richards H. Hearing loss due to mumps. Arch Dis Child. 1987;62:189–191
  13. Information Services Division. Provision of Healthcare. In: Scottish Health Services Costs 2002/2003. Edinburgh: ISD 2004.
  14. Meningococcal C Immunisation Programme Implementation Group. Meningococcal Group C Immunisation Programme in Scotland: Final Report 2001. (http://www.show.scot.nhs.uk/scieh/documents/MenC_Prog_Scot.pdf).
  15. Mooney JD, Donaghy M. Uptake of group C meningococcal conjugate vaccine in a sample population of 20–24 year olds in Scotland. SCIEH Weekly Report 2004; 38:66–7.
  16. Netten A, Dennett J, Knight J. Unit Costs of Health and Social Care. Canterbury: PSSRU, University of Kent; 1999;
  17. Plotkin SA. Mumps Vaccine. In:  Plotkin SA,  Orenstein WA editor. Vaccines. Philadelphia: W.B. Saunders; 2004;
  18. Pugh RN, Akinosi B, Pooransingh S, Kumar J, Grant S, Livesley E, et al. An outbreak of mumps in the metropolitan area of Walsall, UK. Int J Infect Dis. 2002;6:283–287
  19. Reaney EA, Tohani VK, Devine MJ, Smithson RD, Smyth B. Mumps outbreak among young people in Northern Ireland. Commun Dis Public Health. 2001;4:311–315
  20. Sosin DM, Cochi SL, Gunn RA, Jennings CE, Preblud SR. Changing epidemiology or mumps and its impact on university campuses. Pediatrics. 1989;84:779–784
  21. Stover BH, Adams G, Kuebler CA, Cost KM, Rabalais GP. Measles-mumps-rubella immunization of susceptible hospital employees during a community measles outbreak: cost-effectiveness and protective efficacy. Infect Control Hosp Epidemiol. 1994;15:18–21
  22. van Loon FPL, Holmes SJ, Sirotkin BI, Williams WW, Cochi SL, Hadler SC, et al. Mumps Surveillance—United States 1988–1993. MMWR Morb Mortal Wkly Rep. 1995;44:1–14
  23. Wallace LA, Young D, Brown A, Cameron JC, Ahmed S, Duff R, et al. Costs of running a universal adolescent Hepatitis B vaccination programme. Vaccine. 2005;23:5624–5631
  24. Wechner H, Morris RML, Hunt D, Jin L, Stuart J, et al. A secondary school outbreak of mumps following the childhood immunization programme in England and Wales. Epidemiol Infect. 2000;124:131–136
  25. World Health Organisation. Mumps virus vaccines. WHO position paper. Wkly Epidemiol Rec 2001; 76:345–56.

PII: S1386-6532(05)00266-0

doi: 10.1016/j.jcv.2005.09.009

Journal of Clinical Virology
Volume 35, Issue 2 , Pages 121-129 , February 2006

Article Tools

* Image Usage & Resolution